INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

20,958 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
11
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$106K
534 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

Page 439 of 524
← PrevNext →
11
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL
$18K
262 sh
Jan 5, 2026
Jan 6, 2026
traded Jan 5, 2026
+1d
SEC Form 4

Evidence

10
MJ
Malcolm JanDirector
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$25K
50 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
161 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
86 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
52 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

8
GJ
Graham-Cumming JohnDirector
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
177 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

7
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$295K
1,292 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

7
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$381K
1,659 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

6
SN
Sieffert Kristen NPresident
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$18K
750 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$17K
91 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$3,918
21 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$8,850
46 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$39K
207 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

0
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$19K
102 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

60
RV
Raghunathan VivekSVP, Engineering and Support
SNOWSnowflake Inc.
Open-market sale
SELL$2.60M
11.8K sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

53
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Open-market sale
SELL$1.92M
108.6K sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

43
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Open-market sale
SELL$5.85M
346.1K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

43
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Open-market sale
SELL$3.05M
175.7K sh
Jan 5, 2026Jan 5, 2026
traded Jan 5, 2026
+0dSEC Form 4

Evidence

31
RR
Renninger RobertChief Financial Officer
ATHALeonaBio, Inc.
Open-market sale
SELL$2,043
297 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

25
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$17K
203 sh
Dec 31, 2025Jan 5, 2026
traded Dec 31, 2025
+5dSEC Form 4

Evidence

24
PE
Perros EvangelosChief Financial Officer
PGYPagaya Technologies Ltd.
Open-market sale
SELL$224K
9,750 sh
Jan 5, 2026Jan 5, 2026
traded Jan 5, 2026
+0dSEC Form 4

Evidence

21
UJ
Uczekaj JohnDirector, President and COO
AIROAIRO Group Holdings, Inc.
Open-market sale
SELL$1,725
183 sh
Jan 5, 2026Jan 5, 2026
traded Jan 5, 2026
+0dSEC Form 4

Evidence

21
TK
Truong KristinaChief Accounting Officer
ENVXEnovix Corp
Open-market sale
SELL$17K
2,296 sh
Jan 1, 2026Jan 5, 2026
traded Jan 1, 2026
+4dSEC Form 4

Evidence

20
FS
Feider StephenChief Financial Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$591K
20.0K sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

13
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$213K
7,200 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

6
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
600 sh
Jan 2, 2026Jan 5, 2026
traded Jan 2, 2026
+3dSEC Form 4

Evidence

48
AE
Allison EricChief Product Officer
JOBYJoby Aviation, Inc.
Open-market sale
SELL$430K
32.4K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

45
LS
Liu SuyingDirector, CEO and CFO, 10% Owner
MCAGUMountain Crest Acquisition Corp. V
Open-market sale
SELL$1.00M
200.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

45
MH
Mountain Crest Global Holdings LLC10% Owner
MCAGUMountain Crest Acquisition Corp. V
Open-market sale
SELL$1.00M
200.0K sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

40
MZ
McIver ZachariahChief Medical Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$37K
2,714 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

40
DS
Dhaliwal Harpreet S.Chief Technical Ops Officer
PCVXVaxcyte, Inc.
Open-market sale
SELL$455K
9,743 sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

40
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$20K
1,462 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

39
CA
Campbell David AlanDirector, President and CEO
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$111K
8,072 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

38
Ehikian Stephen BradleyChief Executive Officer
AIC3.ai, Inc.
Open-market sale
SELL$3.19M
234.9K sh
Dec 31, 2025Jan 2, 2026
traded Dec 31, 2025
+2dSEC Form 4

Evidence

36
DT
DiRaimondo ThomasChief Scientific Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$34K
2,505 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

36
WM
Winter Charles M.Chief Technical Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$33K
2,401 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

32
MH
Meyer Andrew HollmanChief Business Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$26K
1,879 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC Form 4

Evidence

30
YS
Yoon SungSVP
KEYSKeysight Technologies, Inc.
Open-market sale
SELL$184K
889 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence

27
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$620K
8,089 sh
Dec 30, 2025Jan 2, 2026
traded Dec 30, 2025
+3dSEC Form 4

Evidence